| Literature DB >> 24649001 |
Makiko Nitta1, Kazuo Azuma1, Keishi Hata2, Saori Takahashi2, Kikumi Ogiwara3, Takeshi Tsuka1, Tomohiro Imagawa1, Inoru Yokoe1, Tomohiro Osaki1, Saburo Minami1, Yoshiharu Okamoto1.
Abstract
Melanoma is the most aggressive type of skin cancer and it is procured from activated or genetically altered epidermal melanocytes. In the present study, the tumor-suppressive effects of systemic and local injections of lupeol, a triterpene extracted from Indian lettuce (Lactuca indica), in a melanoma-bearing mouse model were evaluated. Mice were injected once with lupeol or olive oil (solvent control) subcutaneously into the skin of the back or into the tumor tissue. Seven days after the injection, the tumor growth rates were calculated and the tumor tissues were collected. Immunohistochemical staining for Ki-67 and proliferating cell nuclear antigen (PCNA) were performed. The tumor growth rates in the lupeol-injected group were significantly decreased compared to those observed in the non-treated (NT) and solvent control groups. Lupeol also significantly decreased the areas positively stained for Ki-67 and PCNA in the tumor tissues compared to those in the NT and solvent control groups. The results of the present study demonstrated that systemic and local injections of lupeol suppress tumor growth and induce cell cycle arrest in a melanoma-bearing mouse model. These data suggest that lupeol may be effective as a novel therapeutic option for melanoma patients.Entities:
Keywords: Ki-67; anticancer; lupeol; melanoma; proliferating cell nuclear antigen; systemic injection
Year: 2013 PMID: 24649001 PMCID: PMC3917038 DOI: 10.3892/br.2013.116
Source DB: PubMed Journal: Biomed Rep ISSN: 2049-9434